Post Tease Icon

Note on Technology-Internet

Continuous improvement in continuous glucose monitoring

Continuous glucose monitoring (CGM) use is nearing a tipping point, as slow incremental improvements in accuracy over the last decade have reached a point where these devices can now reliably be paired with insulin pumps to create a type of artificial pancreas. Although most current users of CGM are people with type 1 diabetes who are also on insulin pumps, two studies released today show the benefit of CGM use in people with type 1 diabetes not on insulin pumps, but who take multiple insulin injections each day. The next steps will come from reduced costs of usage, so that this technology can then be applied to the millions of people with type 2 diabetes.

Diamond Study, Gold Study, editorial

Share this on Twitter

You might also like

Off the beaten path Psychosocial

You don’t know me

This moving essay from primary care doctor Kate Rowland exposes the disconnection between many dying individuals and their real, non-critically ill identities. This disconnection, since it occurs at the end of life and will remain our most recent mem...

Read More
See more posts